Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2010 Mar;20(2):361-6.
doi: 10.1111/j.1750-3639.2009.00285.x. Epub 2009 May 22.

Diffuse leptomeningeal glioneuronal tumors: a new entity?

Affiliations
Case Reports

Diffuse leptomeningeal glioneuronal tumors: a new entity?

Marina Paola Gardiman et al. Brain Pathol. 2010 Mar.

Abstract

The peculiar radiological and pathological findings of four pediatric cases admitted to the University Hospital of Padua between 1990 and 2007 are described. In all cases, the contrast-enhanced head and spine magnetic resonance images revealed thickened and abnormally enhancing subarachnoid spaces particularly at the level of basal cisterns and interhemispheric fissure. Furthermore, small cystic lesions scattered throughout the brain and mainly in the cerebellum were also visible. All patients were missing a well-defined intraparenchymal mass, although during the follow-up a small intramedullary lesion appeared within the cervical spine in two and subsequently in the frontal horn of the left lateral ventricle in one of those. All patients presented an indolent long-term follow-up. Histologically, the tumors were composed by a monotonous population of cells arranged in straight lines or in small lobules. The cells were characterized by round to oval nuclei with finely granular dispersed chromatin, inconspicuous nucleoli with oligodendrocyte-like features. The morphological and immunohistochemical findings suggested in all cases a "glioneuronal commitment" of the tumors. Because of the unique similar clinical and neuroradiological characteristics, we propose this small series of tumors as a new possible distinct pathological and clinical entity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative neuroradiological features of the described tumors at initial presentation. A,B. Axial T2 images show cystic lesions diffusely scattered throughout the surface of the cerebellum, brain stem, mesial temporal lobes and basal frontal lobes. C. Axial and D. coronal contrast‐enhanced T1 images demonstrate thickening and enhancement of the leptomeninges. A tetraventricular communicating hydrocephalus is also present. E. Spinal sagittal T2 image reveals small cystic lesions involving the posterior surface of the conus midollaris (black arrows). F. Corresponding contrast‐enhanced T1 image demonstrates a marked nodular and linear leptomeningeal enhancement involving the spinal cord and the cauda equina; the intra‐axial cysts do not enhance. Spinal axial. G. T2 and H. contrast‐enhanced T1 images at cervical level show a small superficial leptomeningeal enhancing nodule (white arrow) and an underlying intramedullary cyst (open arrow). I. Sagittal contrast‐enhanced T1 images depict a small intramedullary lesion posterior to C3‐C4 (white arrow) and a marked cerebral and spinal leptomeningeal enhancement coexisting with a tetraventricular communicating hydrocephalus and an empty sella. Small non‐enhancing cysts are scattered throughout the cerebellar and pontine surface. (A,C,DH case #1; B and I, case #3).
Figure 2
Figure 2
Representative histopathological features of the described tumors. A. Thickened leptomeninges diffusely infiltrated by neoplastic cells. B. Tumors were composed by a monotonous population of round cells arranged in straight lines. C. Pseudopapillary pattern of neoplastic growth. D. Cuboidal glial cells intermingled with neurocytes and ganglioid cells. E. Intratumoral neural pseudorosettes were also observed. F. Oligodendrocyte‐like honeycomb appearance. G. Strongly cytoplasmatic synaptophysin‐immunoreactive tumor cells. H. Nuclear Neu‐N‐immunoreactive neurocytic component. Original magnifications 10×, 20× and 40×. (A, case #1; B, case #4; CH, case #3).

References

    1. Armao DM, Stone J, Castillo M, Mitchell KM, Bouldin TW, Suzuki K (2000) Diffuse leptomeningeal oligodendrogliomatosis: radiologic/pathologic correlation. AJNR Am J Neuroradiol 21:1122–1126. - PMC - PubMed
    1. Bae JY, Choi BO, SunWoo IN, Kim DI, Cho SH, Kim TS (2000) Diffuse cerebrospinal gliomatosis with extensive leptomeningeal spread. Yonsei Med J 41:517–521. - PubMed
    1. Bourne TD, Mandell JW, Matsumoto JA, Jane JA Jr, Lopes BS (2006) Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. J Neurosurg 105:465–469. - PubMed
    1. Brandes AA, Tosoni A, Cavallo G, Reni M, Franceschi E, Bonaldi L et al (2006) Correlation between O6‐methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study. J Clin Oncol 24:4746–4753. - PubMed
    1. Chen R, Chir B, MacDonald DR, Ramsay DA, Phil D (1995) Primary diffuse leptomeningeal oligodendroglioma. Case report. J Neurosurg 83:724–728. - PubMed

Publication types

MeSH terms